Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Perera

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|September 4, 2023
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicatingNikhila S Tanneti, Anant K Patel, Li Hui Tan, et al.
BMJ Open|May 19, 2026
Seroprevalence of COVID-19 among healthcare workers in Hong Kong during the first 2 years of the COVID-19 pandemic (2020-2021): a longitudinal cohort studyWey Wen Lim, Loretta Mak, Faith Ho, et al.
Emerging Infectious Diseases|August 5, 2020
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus DiseaseRanawaka A P M Perera, Eugene Tso, Owen T Y Tsang, et al.
Nature Immunology|August 19, 2020
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infectionAsmaa Hachim, Niloufar Kavian, Carolyn A Cohen, et al.
Mbio|March 13, 2024
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicatingNikhila S Tanneti, Anant K Patel, Li Hui Tan, et al.
The Journal of Infectious Diseases|January 4, 2021
Tropism of SARS-CoV-2, SARS-CoV, and Influenza Virus in Canine Tissue ExplantsChristine H T Bui, Hin Wo Yeung, John C W Ho, et al.
Emerging Infectious Diseases|December 20, 2019
Influenza A Virus Infections in Dromedary Camels, Nigeria and Ethiopia, 2015-2017Daniel K W Chu, Ranawaka A P M Perera, Abraham Ali, et al.
NPJ Vaccines|February 17, 2021
Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adultsAthena P Y Li, Carolyn A Cohen, Nancy H L Leung, et al.
The Lancet. Infectious Diseases|October 9, 2020
T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort studyChris Ka Pun Mok, Airu Zhu, Jingxian Zhao, et al.
Emerging Infectious Diseases|June 7, 2017
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Pyoeng Gyun Choe, R A P M Perera, Wan Beom Park, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|September 4, 2023
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicatingNikhila S Tanneti, Anant K Patel, Li Hui Tan, et al.
BMJ Open|May 19, 2026
Seroprevalence of COVID-19 among healthcare workers in Hong Kong during the first 2 years of the COVID-19 pandemic (2020-2021): a longitudinal cohort studyWey Wen Lim, Loretta Mak, Faith Ho, et al.
Emerging Infectious Diseases|August 5, 2020
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus DiseaseRanawaka A P M Perera, Eugene Tso, Owen T Y Tsang, et al.
Nature Immunology|August 19, 2020
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infectionAsmaa Hachim, Niloufar Kavian, Carolyn A Cohen, et al.
Mbio|March 13, 2024
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicatingNikhila S Tanneti, Anant K Patel, Li Hui Tan, et al.
The Journal of Infectious Diseases|January 4, 2021
Tropism of SARS-CoV-2, SARS-CoV, and Influenza Virus in Canine Tissue ExplantsChristine H T Bui, Hin Wo Yeung, John C W Ho, et al.
Emerging Infectious Diseases|December 20, 2019
Influenza A Virus Infections in Dromedary Camels, Nigeria and Ethiopia, 2015-2017Daniel K W Chu, Ranawaka A P M Perera, Abraham Ali, et al.
NPJ Vaccines|February 17, 2021
Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adultsAthena P Y Li, Carolyn A Cohen, Nancy H L Leung, et al.
The Lancet. Infectious Diseases|October 9, 2020
T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort studyChris Ka Pun Mok, Airu Zhu, Jingxian Zhao, et al.
Emerging Infectious Diseases|June 7, 2017
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Pyoeng Gyun Choe, R A P M Perera, Wan Beom Park, et al.
Pageof 9